Hosted on MSN3d
CVS Health Stock Gets RS Rating Upgrade
CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...
Stifel Nicolaus Remains a Buy on Astrana Health (ASTH)
Stifel Nicolaus analyst Michael Craig Jones maintained a Buy rating on Astrana Health (ASTH – Research Report) today and set a price target of ...
Astrana Health price target lowered to $56 from $70 at Stifel
Stifel lowered the firm’s price target on Astrana Health (ASTH) to $56 from $70 and keeps a Buy rating on the shares ahead of Astrana reporting ...
Astrana Health, Inc. Schedules 2024 Fourth Quarter and Full Year Financial Results Release and Conference Call
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling ...